Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Osteobrix Plus is an approved combination nutritional supplement developed by Stevia Pharmaceuticals in India. It is formulated as a softgel capsule containing elemental calcium, calcitriol (the active hormonal form of Vitamin D3), methylcobalamin (Vitamin B12), folic acid (Vitamin B9), and pyridoxine (Vitamin B6). Calcitriol functions as a Vitamin D receptor (VDR) agonist, enhancing intestinal calcium absorption and promoting bone mineralization, while elemental calcium provides the structural component for bone tissue. The inclusion of B-vitamins addresses common nutritional deficiencies and supports neurological and metabolic health. It is primarily indicated for the management of bone health and nutritional deficiencies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Osteobrix Plus.